Background: Apoptolidin is a macrolide originally identified on the basis o
f its ability to selectively kill E1A and E1A/E1B19K transformed rat glial
cells while not killing untransformed glial cells. The goal of this study w
as to identify the molecular target of this newly discovered natural produc
t,
Results: Our approach to uncovering the mechanism of action of apoptolidin
utilized a combination of molecular and cell-based pharmacological assays a
s well as structural comparisons between apoptolidin and other macrocyclic
polyketides with known mechanism of action. Cell killing induced by apoptol
idin was independent of p53 status, inhibited by BCL-2, and dependent on th
e action of caspase-9. PARP was completely cleaved in the presence of 1 muM
apoptolidin within 6 h in a mouse lymphoma cell line. Together these resul
ts suggested that apoptolidin might target a mitochondrial protein. Structu
ral comparisons between apoptolidin and other macrolides revealed significa
nt similarity between the apoptolidin aglycone and oligomycin, a known inhi
bitor of mitochondrial F0F1-ATP synthase. The relevance of this similarity
was established by demonstrating that apoptolidin is a potent inhibitor of
the F0F1-ATPase activity in intact yeast mitochondria as well as Triton X-1
00-solubilized ATPase preparations. The K-i For apoptolidin was 4-5 muM. Th
e selectivity of apoptolidin in the NCI-60 cell line panel was found to cor
relate well with that of several known anti-fungal natural products that in
hibit the eukaryotic mitochondrial F0F1-ATP synthase.
Significance: Although the anti-fungal activities of macrolide inhibitors o
f the mitochondrial F0F1-ATP synthase such as oligomycin, ossamycin and cyt
ovaricin are well-documented, their unusual selectivity toward certain cell
types is not widely appreciated. The recent discovery of apoptolidin. foll
owed by the demonstration that it is an inhibitor of the mitochondrial FI,F
I-ATP synthase, highlights the potential relevance of these natural product
s as small molecules to modulate apoptotic pathways. The mechanistic basis
for selective cytotoxicity of mitochondrial ATP synthase inhibitors is disc
ussed. (C) 2001 Elsevier Science Ltd. All rights reserved.